GSK to use 23andMe’s DNA library in drug development

DNA testing company 23andMe has partnered with pharmaceutical giant GlaxoSmithKline (GSK), in a bid to develop new drug treatments. 23andMe, which gives customers insight into their genetic makeup via postal saliva tests, has some five million custom…

No Responses to “GSK to use 23andMe’s DNA library in drug development”

Post a Comment